| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CI | Common Stock, $.01 Par Value | Options Exercise | $580K | +4.8K | +12.01% | $120.90 | 44.7K | Jun 24, 2024 | Direct | F1 |
| transaction | CI | Common Stock, $.01 Par Value | Sale | -$1.65M | -4.8K | -10.72% | $345.01 | 39.9K | Jun 24, 2024 | Direct | F1, F2 |
| transaction | CI | Common Stock, $.01 Par Value | Options Exercise | $122K | +1.01K | +2.53% | $120.90 | 40.9K | Jun 25, 2024 | Direct | F1 |
| holding | CI | Common Stock, $.01 Par Value | 883 | Jun 24, 2024 | By 401(k) | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CI | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -4.8K | -82.59% | $0.00 | 1.01K | Jun 24, 2024 | Common Stock, $.01 Par Value | 4.8K | $120.90 | Direct | F1, F4 |
| transaction | CI | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -1.01K | -100% | $0.00* | 0 | Jun 25, 2024 | Common Stock, $.01 Par Value | 1.01K | $120.90 | Direct | F1, F4 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024. |
| F2 | Represents the weighted average price of the shares sold. The prices actually received ranged from $345.00 to $345.07 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. |
| F3 | Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan. |
| F4 | This option was granted on February 25, 2015. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date. |
EVP, Chief Financial Officer and President & CEO, Cigna Healthcare